Activation of the Nrf2 antioxidant pathway has been reported to not only prevent LPS-induced expression of pro-inflammatory cytokines and inflammatory factors but targeting Nrf2 signaling as an effective approach to treating colitis [14,32]. The gene discussed is NFE2L2; the disease is colitis.